website translator plugin
A Division of ViaDerma, Inc. , A Public Company.

Breakthrough Rapid Delivery of Nutrients and Medicines

  • image wide 1

ViaDerma, Inc. is a specialty pharmaceutical company committed to bringing new products to market through innovative research & development. ViaDerma licenses products in fields of medicine ranging from infectious diseases to wound care.

About Us

Founded in 2014 by Dr. Christopher Otiko, ViaDerma, Inc. (VDRM) is a publicly traded specialty pharmaceutical company committed to bringing new products to market and licensing its innovative technology to current leaders in the pharmaceutical industry in a wide variety of therapeutic areas. ViaDerma's lead product, TetraStem, uses an innovative transdermal delivery method to apply almost any active ingredient to a topical drug.

This patent-pending dual carrier transdermal technology may be applied in products within the medical and cosmetic markets.

Technology

Innovative, patent pending dual carrier transdermal technology which can transform oral medication into topical products.

Ability to enable active ingredients with a rapid transport direct to the site of action.

Ability to be used in any field including Sports Nutrition Supplements, Cosmetics, First Aid Products, Wound Care, and Skin Diseases like Acne, Eczema, and Psoriasis.

Dual carrier liquid which can possess life enhancing technology with up to four year shelf-life.

Facilitates transfer of chemicals through the stratum corneum with a diffusion constant 10,000x higher.

Our transdermal technology was used in a product which received the Bronze Award for “2012 Best New Pharmaceutical Product” at the 25th Annual Edison Awards in New York City

Named the winner of the “Drug Store News Best New Product” as voted by key pharmacy industry decision makers at the ECRM® Marketgate™ 2012 meetings held in Charlotte, NC.

Strong Advanced Biological Coverage (ABC) which has higher concentrations, faster penetration and is more effective than conventional antibiotics. ABC produces desirable results in ~24 hours or less compared to 5-7 days. It kills all harmful gram-positive and gram-negative bacteria that have been available for testing.

USAGE & APPLICATION

Lead Product TetraStem

World’s strongest broad spectrum tetracycline-based topical antibiotic with proven results.

Used for cuts, scrapes, wounds, infections, burns, acne, psoriasis, eczema, and minor injuries.

Very low water content and optimum (low) viscosity.

Uses both a chemical AND physical kill mechanism which is advantageous over traditional antibiotics which use only a chemical kill mechanism and has a better resistance profile.

Potential Markets

ViaDerma is developing products in many fields of use, including:

  • Topical antibiotics- $6 billion/year
  • Toenail antifungal drugs- $3 billion/year
  • Diabetic amputations- $3 billion/year
  • Global acne- $2.8 million in 2009, estimates of $3.02 billion by 2016
  • Psoriasis- $2.4 billion in 2010, estimates of over $7.3 billion by 2015
  • Eczema- $2.5 billion in 2014

Other potential markets include burns, anti-aging/wrinkle remover cream, medical cannabis, male-pattern baldness, skin cancer, erectile dysfunction, and pain management.

Case Studies

Click the icon below to download PDF

 
Warning: GRAPHIC CONTENT

News

Contact Details

ViaDerma's global Headquarters is located at
4640 Admiralty Way Suite 500Marina Del Rey, CA 90292.

Phobe: 310-496-5744 | Fax: 310-943-1457